Presentation ACC 2018 6-Month versus 12-Month or Longer Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome (SMART-DATE) Presenter: Hyeon-Cheol Gwon March 12, 2018
Presentation ACC 2018 The PHARMCLO Study: A Prospective, Randomised, Multicentre Study of a Pharmacogenomic Approach to the Selection of Antiplatelet Therapy in Acute Coronary Syndromes Presenter: Diego Ardissino March 12, 2018
News Conference News ACC 2018 SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients Michael O'Riordan March 11, 2018
News Conference News ACC 2018 TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis Shelley Wood March 11, 2018
News Conference News ACC 2018 ACC 2018, Day Two: Antiplatelets in ACS, Dabigatran in Noncardiac Surgery, and More Shelley Wood March 11, 2018
Presentation ACC 2018 The ODYSSEY OUTCOMES Trial: Topline Results Alirocumab in Patients After Acute Coronary Syndrome Presenter: Philippe Gabriel Steg March 10, 2018
News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018